Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium

Taizo Uchimoto(Osaka University of Pharmaceutical Sciences), Haruhito Azuma(Osaka University of Pharmaceutical Sciences), Takuya Tsujino(Osaka University of Pharmaceutical Sciences), Tomoaki Takai(Osaka University of Pharmaceutical Sciences), Atsuhiko Yoshizawa(Fujita Health University Hospital), Mamoru Hashimoto(University of Pittsburgh), Fumihiko Urabe(Jikei University School of Medicine), Kosuke Iwatani(Jikei University School of Medicine), Takafumi Minami(Kindai University), Shogo Yamazaki(Osaka University of Pharmaceutical Sciences), Ryoichi Maenosono(Osaka University of Pharmaceutical Sciences), Yuki Yoshikawa(Hiroshima Prefectural Hospital), Wataru Fukuokaya(Jikei University School of Medicine), Keiichiro Mori(Jikei University School of Medicine), Kazuki Nishimura(Osaka University of Pharmaceutical Sciences), Kyosuke Nishio(Osaka University of Pharmaceutical Sciences), Takafumi Yanagisawa(Jikei University School of Medicine), Takahiro Adachi(Tokyo Medical University), Shunsuke Tsuduki(Jikei University School of Medicine), Ko Nakamura, Shutaro Yamamoto, Masanobu Saruta(Fujita Health University), Yoshio Ohno(Tokyo Medical University), Takeshi Hashimoto(Tokyo Medical University), Kazumasa Komura(Kawasaki Medical School), Kazutoshi Fujita(Kindai University), Ryoichi Shiroki(Fujita Health University), Takahiro Kimura(Jikei University School of Medicine), Yuki Nakajima(Osaka University of Pharmaceutical Sciences), Tatsuo Fukushima(Osaka University of Pharmaceutical Sciences), Moritoshi Sakamoto(Osaka University of Pharmaceutical Sciences), Kengo Iwatsuki(Osaka University of Pharmaceutical Sciences), Kiyoshi Takahara(Osaka Medical and Pharmaceutical University), Yutaka Yamamoto(Kindai University), Yosuke Hirasawa(Cedars-Sinai Medical Center)
International Journal of Clinical Oncology
January 31, 2025
Cited by 4


Related Papers